Type i and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

Cellular and Molecular Immunology

Volumn 8, Issue 4, 2011, Pages 341-347

  Nguyen Pham, Thanh Nhan ^a   Lim, Mi Seon ^a   Nguyen, Truc Anh Thi ^a   Lee, Youn Kyung ^a,b   Jin, Chun Ji ^a   Lee, Hyun Ju ^a   Hong, Cheol Yi ^a   Ahn, Jae Sook ^a   Yang, Deok Hwan ^a   Kim, Yeo Kyeoung ^a   Chung, Ik Joo ^a   Park, Byoung Chul ^c   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a,b  

^a Chonnam National University   (South Korea)

^b Vaxcell Bio Therapeutics   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

CD38; CD74; dendritic cells; interferon; Toll like receptor

Indexed keywords

ALPHA INTERFERON; CD38 ANTIGEN; CD74 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; NORMAL HUMAN; PROTEIN EXPRESSION;

ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CCL21; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; RECEPTORS, CCR7; TH1 CELLS; TOLL-LIKE RECEPTORS;

EID: 79960067341     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.7     Document Type: Article

References (25)

1. Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood 2002; 100: 1362-1372. (Pubitemid 34864293)
2. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100: 1354-1361. (Pubitemid 34864292)
3. Morelli AE, Thomson AW. Dendritic cells under the spell of prostaglandins. Trends Immunol 2003; 24: 108-111. (Pubitemid 36263091)
4. Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a1CD831 dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 1998; 161: 2804-2809. (Pubitemid 28425700)
5. Kaisho T, Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 2003; 3: 373-385. (Pubitemid 36621794)
6. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005; 6: 769-776. (Pubitemid 43090462)
7. Krumbiegel D, Zepp F, Meyer CU. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum Immunol 2007; 68, 813-822. (Pubitemid 47599716)
8. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 15: 95-97. (Pubitemid 24076322)
9. Partida-Sanchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med 2001; 7: 1209-1216. (Pubitemid 33063776)
10. Gasser A, Bruhn S, Guse AH. Second messenger function of nicotinic acid adenine dinucleotide phosphate revealed by an improved enzymatic cycling assay. J Biol Chem 2006; 281: 16906-16913.
11. Bruzzone S, de Flora A, Usai C, Graeff R, Lee HC. Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells. Biochem J 2003; 375: 395-403. (Pubitemid 37315447)
12. Partida-Sanchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, Lund FE. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 2004; 20: 279-291. (Pubitemid 38388230)
13. Fedele G, Frasca L, Palazzo R, Ferrero E, Malavasi F, Ausiello CM. CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction. Eur J Immunol 2004; 34: 1342-1350. (Pubitemid 39256013)
14. Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, Vaisitti T et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2006; 107: 2392-2399. (Pubitemid 43345559)
15. Faure-Andre G, Vargas P, Yuseff MI, Heuze M, Diaz J, Lankar D et al. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 2008; 322: 1705-1710.
16. Luft T, Luetjens P, Hochrein H, Toy T, Masterman KA, Rizkalla M et al. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002; 14: 367-380. (Pubitemid 34257764)
17. Padovan E, Spagnoli GC, Ferrantini M, Heberer M. IFN-alpha2a induces IP-10/ CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD81 effector T cells. J Leukoc Biol 2002; 71: 669-676.
18. Frasca L, Nasso M, Spensieri F, Fedele G, Palazzo R, Malavasi F et al. IFN-gamma arms human dendritic cells to perform multiple effector functions. J Immunol 2008; 180: 1471-1481.
19. Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML et al. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004; 64: 5934-5937. (Pubitemid 39129387)
20. Giermasz AS, Urban JA, Nakamura Y, Watchmaker P, Cumberland RL, Gooding W et al. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunol Immunother 2009; 58: 1329-1336.
21. Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 2008; 68: 5972-5978.
22. Takeda K, Akira S. Microbial recognition by Toll-like receptors. J Dermatol Sci 2004; 34: 73-82. (Pubitemid 38368945)
23. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001; 294: 870-875. (Pubitemid 33032108)
24. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin- and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-752. (Pubitemid 26324129)
25. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998; 10: 1593-1598. (Pubitemid 28502373)